DS
BVS icon

David Shaw’s Bioventus BVS Stock Holding History

David Shaw’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Sell
47,304
-263,306
-85% -$2.51M ﹤0.01% 4235
2026
Q1 		$2.84M Sell
310,610
-47,647
-13% -$400K ﹤0.01% 2640
2025
Q4 		$2.67M Buy
358,257
+169,365
+90% +$1.22M ﹤0.01% 2816
2025
Q3 		$1.26M Buy
188,892
+118,450
+168% +$822K ﹤0.01% 3306
2025
Q2 		$466K Sell
70,442
-97,309
-58% -$690K ﹤0.01% 3672
2025
Q1 		$1.53M Buy
167,751
+7,095
+4% +$70.9K ﹤0.01% 2802
2024
Q4 		$1.69M Sell
160,656
-160,974
-50% -$1.9M ﹤0.01% 2850
2024
Q3 		$3.84M Buy
321,630
+124,455
+63% +$1.08M ﹤0.01% 2162
2024
Q2 		$1.13M Buy
+197,175
New +$1.08M ﹤0.01% 3105
2024
Q1 		– Sell
-35,910
Closed -$189K – 4365
2023
Q4 		$189K Buy
+35,910
New +$142K ﹤0.01% 3892
2023
Q2 		– Sell
-18,300
Closed -$19.6K – 4259
2023
Q1 		$19.6K Buy
18,300
+5,700
+45% +$10.9K ﹤0.01% 4147
2022
Q4 		$32.9K Buy
+12,600
New +$55K ﹤0.01% 4472
2021
Q4 		– Sell
-15,024
Closed -$213K – 5416
2021
Q3 		$213K Buy
+15,024
New +$231K ﹤0.01% 4538

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David Shaw's BVS Position: Q2 2026 in Review

David Shaw reduced its Bioventus (BVS) stake by 85% in Q2 2026, selling an estimated $2.51M and leaving 47,304 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #4235.

David Shaw first reported a position in BVS in Q3 2021 and has held it in 13 quarters since. The position peaked at $3.84M in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • David Shaw held 47,304 shares of Bioventus worth $447K as of Q2 2026.
  • David Shaw sold 263,306 Bioventus shares in Q2 2026, an estimated $2.51M.
  • Bioventus made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4235 holding.
  • David Shaw first reported a position in Bioventus in Q3 2021 and has held it in 13 quarters since.
  • David Shaw's Bioventus position peaked at $3.84M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.